Cited by 227Influenza Virus Research StudiesEvolution and Genetic DynamicsRespiratory viral infections research

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Vaccination and antigenic drift in influenza

Open access

Boni, Maciej F.·2008·Vaccine

DOI 10.1016/j.vaccine.2008.04.011PMC PMC2603026

Open this paper in CoChat — free account

Abstract

The relationship between influenza antigenic drift and vaccination lies at the intersection of evolutionary biology and public health, and it must be viewed and analyzed in both contexts simultaneously. In this paper, 1 review what is known about the effects of antigenic drift on vaccination and the effects of vaccination on antigenic drift, and I suggest some simple ways to detect the presence of antigenic drift in seasonal influenza data. If antigenic drift occurs on the time scale of a single influenza season, it may be associated with the presence of herd immunity at the beginning of the season and may indicate a need to monitor for vaccine updates at the end of the season. The relationship between antigenic drift and vaccination must also be viewed in the context of the global circulation of influenza strains and the seeding of local and regional epidemics. In the data sets I consider--from New Zealand, New York, and France--antigenic drift can be statistically detected during some seasons, and seeding of epidemics appears to be endogenous sometimes and exogenous at other times. Improved detection of short-term antigenic drift and epidemic seeding would significantly benefit influenza monitoring efforts and vaccine selection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2008.04.011

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Evolution and ecology of influenza A viruses
Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., & Kawaoka, Y. (1992) · Microbiological Reviews · doi:10.1128/mr.56.1.152-179.1992 · Cited by 4,739
Mapping the Antigenic and Genetic Evolution of Influenza Virus
Smith, D. J., Lapedes, A. S., de Jong, J. C., Bestebroer, T. M., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2004) · Science · doi:10.1126/science.1097211 · Cited by 1,868
Unifying the Epidemiological and Evolutionary Dynamics of Pathogens
Grenfell, B. T., Pybus, O. G., Gog, J. R., Wood, J. L. N., Daly, J. M., MUMFORD, J. A., & Holmes, E. C. (2004) · Science · doi:10.1126/science.1090727 · Cited by 1,370
Herd Immunity: History, Theory, Practice
Fine, P. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036121 · Cited by 906
Global Epidemiology of Influenza: Past and Present
Cox, N. J., & Subbarao, K. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.407 · Cited by 838
Synchrony, Waves, and Spatial Hierarchies in the Spread of Influenza
Viboud, C. G., Bjørnstad, O. N., Smith, D. L., Simonsen, L., Miller, M. A., & Grenfell, B. T. (2006) · Science · doi:10.1126/science.1125237 · Cited by 832
The theory of gene frequencies
Wright, S. (1969) · University of Chicago Press eBooks · Cited by 755
Ecological and immunological determinants of influenza evolution.
Ferguson, N. M., Galvani, A. P., & Bush, R. M. (2003) · Nature · doi:10.1038/nature01509 · Cited by 746
Structural Basis of Immune Recognition of Influenza Virus Hemagglutinin
Wilson, I. A., & Cox, N. J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003513 · Cited by 571
The annual production cycle for influenza vaccine
Gerdil, C. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00071-9 · Cited by 529

Show all 48 references

Sorted by citations

Items 101–200 of 227

High performance of rapid influenza diagnostic test and variable effectiveness of influenza vaccines in Mexico
Castillejos-López, M. D. J., Cabello-Gutiérrez, C., Choreño-Parra, J. A., Hernández, V., Romo, J., Hernández‐Sánchez, F., Martínez, D., Hernández, A., Jiménez-Álvarez, L. A., Hernández‐Cardenas, C. M., et al. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.08.029 · Cited by 12
An Antigenic Space Framework for Understanding Antibody Escape of SARS-CoV-2 Variants
Miller, N. L., Clark, T., Raman, R., & Sasisekharan, R. (2021) · Viruses · doi:10.3390/v13102009 · Cited by 10
Hotspots for mutations in the SARS-CoV-2 spike glycoprotein: a correspondence analysis
Rahbar, M. R., Jahangiri, A., Khalili, S., Zarei, M., Mehrabani-Zeinabad, K., Khalesi, B., Pourzardosht, N., Hessami, A., Nezafat, N., Sadraei, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-01655-y · Cited by 13
Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?
Chong, Y., & Ikematsu, H. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1373228 · Cited by 12
Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
Cheng, Z., Ma, J., & Zhao, C. (2024) · Vaccines · doi:10.3390/vaccines12121382 · Cited by 11
Variations in Seasonal Influenza Vaccine Effectiveness due to Study Characteristics: A Systematic Review and Meta-analysis of Test-Negative Design Studies
Okoli, G. N., Racovitan, F., Righolt, C. H., & Mahmud, S. M. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa177 · Cited by 11
How signalling games explain mimicry at many levels: from viral epidemiology to human sociology
Casey, W., Massey, S. E., & Mishra, B. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0689 · Cited by 12
Evidence for Persistence of and Antiviral Resistance and Reassortment Events in Seasonal Influenza Virus Strains Circulating in Cambodia
Fourment, M., Mardy, S., Mey, C., & Buchy, P. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01687-09 · Cited by 11
Effective Immunization of Older Adults Against Seasonal Influenza
Schaffner, W., Chen, W. H., HOPKINS, R. H., & Neuzil, K. M. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.02.019 · Cited by 13
Identification and genomic characterization of influenza viruses with different origin in Mexican pigs
Saavedra‐Montañez, M., Vaca, L. A., Ramírez‐Mendoza, H., Gaitán‐Peredo, C., Martínez‐Bautista, R., Segura‐Velázquez, R. A., Cervantes‐Torres, J. B., & Sánchez‐Betancourt, J. I. (2018) · Transboundary and Emerging Diseases · doi:10.1111/tbed.12998 · Cited by 11
Guided design for the development of an evolution-proof influenza vaccine
Myburgh, L., van Loon, K., Huijbers, E. J. M., B, J. R. V. B., Russell, C. A., & Griffioen, A. W. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127281 · Cited by 11
Novel hemagglutinin inhibitors for H1N1 influenza virus screening from TCM database
Chang, T.-T., Sun, M.-F., Chen, H., Tsai, F., Fisher, M., Lin, J., & Chen, C. Y. (2011) · Molecular Simulation · doi:10.1080/08927022.2010.543973 · Cited by 10
Co-circulation of two genetically distinct sub-groups of A/H3N2 influenza strains during the 2006–2007 epidemic season in Corsica Island, France
Falchi, A., Varesi, L., Arena, C., Lévêque, N., Renois, F., Blanchon, T., Amoros, J. P., & Andréoletti, L. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.05.004 · Cited by 10
Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand
Tewawong, N., Suntronwong, N., Vichiwattana, P., Vongpunsawad, S., Theamboonlers, A., & Poovorawan, Y. (2016) · Virus Genes · doi:10.1007/s11262-016-1347-5 · Cited by 10
Identification of Linear Peptide Immunogens with Verified Broad-spectrum Immunogenicity from the Conserved Regions within the Hemagglutinin Stem Domain of H1N1 Influenza Virus
Li, S., Qiao, Y., Xu, Y., Li, P., Nie, J., Zhao, Q., Chai, W., Shi, Y., Kong, W., & Shan, Y. (2020) · Immunological Investigations · doi:10.1080/08820139.2020.1834579 · Cited by 10
Epitope-targeting platform for broadly protective influenza vaccines
Zeigler, D. F., Gage, E., & Clegg, C. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252170 · Cited by 11
Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicity
Hodgson, D., Sánchez‐Ovando, S., Carolan, L. A., Liu, Y., Hadiprodjo, A. J., Fox, A., Sullivan, S. G., & Kucharski, A. J. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126579 · Cited by 11
Mechanistic insights into the small-molecule inhibition of influenza A virus entry
Xu, Y., Anirudhan, V., Gaisina, I. N., Du, H., Alqarni, S., Moore, T. W., Caffrey, M. S., Manicassamy, B., Zhou, T., Rong, L., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2503899122 · Cited by 9
Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies
Abbadi, N., Nagashima, K. A., Pena-Briseno, A., Ross, T. M., & Mousa, J. J. (2022) · Journal of Virology · doi:10.1128/jvi.00896-22 · Cited by 9
Nanotechnology Platform for Advancing Vaccine Development against the COVID-19 Virus
Chowdhury, N., & Kundu, A. K. (2023) · Diseases · doi:10.3390/diseases11040177 · Cited by 9
The Impact of Matching Vaccine Strains and Post-SARS Public Health Efforts on Reducing Influenza-Associated Mortality among the Elderly
Chan, T., Hsiao, C. K., Lee, C.-C., Chiang, P., Kao, C., Liu, C., & King, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011317 · Cited by 9
High genetic and antigenic similarity between a swine H3N2 influenza A virus and a prior human influenza vaccine virus: A possible immune pressure-driven cross-species transmission
Pan, C., Wang, G., Liao, M., Zhang, G., & Jiang, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.064 · Cited by 9
Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets
Zhang, L., Chen, J., Shen, C., Wang, G., Lu, Z. Z., Zeng, D., Gao, Y., Chen, H., Xia, N., & Chen, Y. (2022) · Vaccines · doi:10.3390/vaccines10081304 · Cited by 8
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice
Jangra, S., Lamoot, A., Singh, G., Laghlali, G., Chen, Y., Ye, T., García‐Sastre, A., Geest, B. G. D., & Schotsaert, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1370564 · Cited by 8
Influenza‐associated mortality in South Africa, 2009‐2013: The importance of choices related to influenza infection proxies
Gul, D., Cohen, C., Tempia, S., Newall, A. T., & Muscatello, D. J. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12498 · Cited by 8
Implementing sequence-based antigenic distance calculation into immunological shape space model
Anderson, C., Sangster, M. Y., Yang, H., Mariani, T. J., Chaudhury, S., & Topham, D. J. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03594-3 · Cited by 8
Vaccine epidemiology, evaluation, and constraints of vaccine effectiveness -A review
Endale, H., Aliye, S., & Mathewos, M. (2022) · Veterinary Vaccine · doi:10.1016/j.vetvac.2022.100004 · Cited by 7
Pharmacodynamic and safety considerations for influenza vaccine and adjuvant design
Sasaki, E., Hamaguchi, I., & Mizukami, T. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1807936 · Cited by 7
Construction high-yield candidate influenza vaccine viruses in Vero cells by reassortment
Yu, W., Yang, F., Yang, J., Ма, Л., Cun, Y., Song, S., & Liao, G. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24558 · Cited by 6
Evolution and Vaccination of Influenza Virus
Lam, H. C., Bi, X., Sreevatsan, S., & Boley, D. L. (2017) · Journal of Computational Biology · doi:10.1089/cmb.2017.0025 · Cited by 6
Double-Stranded Ribonucleic Acid-Mediated Antiviral Response Against Low Pathogenic Avian Influenza Virus Infection
Ahmed-Hassan, H., Abdul-Cader, M. S., Sabry, M. A., Hamza, E., Sharif, S., Nagy, É., & Abdul-Careem, M. F. (2018) · Viral Immunology · doi:10.1089/vim.2017.0142 · Cited by 6
A Recombinant Mosaic HAs Influenza Vaccine Elicits Broad-Spectrum Immune Response and Protection of Influenza a Viruses
Liu, X., Luo, C., Yang, Z., Zhao, T., Yuan, L., Xie, Q., Liao, Q., Liao, X., Wang, L., Yuan, J., et al. (2024) · Vaccines · doi:10.3390/vaccines12091008 · Cited by 6
Understanding the Structure and Function of Viral Glycosylation by Molecular Simulations: State-of-the-Art and Recent Case Studies
Fadda, E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00056-0 · Cited by 5
Mutational signatures in countries affected by SARS-CoV-2: Implications in host-pathogen interactomePreprint
Singh, J., Singh, H., Hasnain, S. E., & Rahman, S. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.17.301614 · Cited by 5
The Importance of Real-World Evidence in Understanding Influenza Vaccine Effectiveness
Ferrara, P., & Mantovani, L. G. (2022) · Farmeconomia Health economics and therapeutic pathways · doi:10.7175/fe.v23i1.1522 · Cited by 4
Antiviral potentials of garlic (Allium sativum) in poultry production: A mini review
Adjei‐Mensah, B., Quaye, B., Opoku, O., & Atuahene, C. C. (2023) · Veterinary Medicine and Science · doi:10.1002/vms3.1247 · Cited by 4
Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons
Hiroi, S., Morikawa, S., Nakata, K., Maeda, A., Kanno, T., Irie, S., Ohfuji, S., Hirota, Y., & Kase, T. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1009338 · Cited by 4
A Joint Matrix Completion and Filtering Model for Influenza Serological Data Integration
Yuan, X., Zhang, T., & Wan, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069842 · Cited by 4
Neuraminidase Gene Variations in Influenza A(H1N1)pdm09 Virus among Patients Admitted to Refferal Pulmonary Hospital, Tehran, Iran in 2009-2013.
Momeni, P., Abedin Dargoosh, S., Aa, S., Bagheri, G., Mohammadi, M., Poos-Ashkan, L., Sigaroodi, A., Sadr, M., & Nadji, S. A. (2017) · Europe PMC (PubMed Central) · Cited by 4
Competitive interference between influenza viral strains
Moghadas, S. M., Bowman, C. S., & Arino, J. (2011) · NPARC · Cited by 4
Vaccine adjuvants as stand-alone immunoprophylaxis in strategies for 100-day rapid responses to future pandemics
Kavian, N., Kobiyama, K., Ishii, K. J., & Coban, C. (2025) · International Immunology · doi:10.1093/intimm/dxaf053 · Cited by 3
VARIABILITY OF THE INFLUENZA A VIRUS
Sobolev, I. A., Kurskaya, O., Sharshov, K., Prokopyeva, E. A., Alekseev, А. Y., Gadzhiev, A. A., & Shestopalov, A. M. (2016) · South of Russia ecology development · doi:10.18470/1992-1098-2016-1-170-177 · Cited by 3
Avian/Bird flu: A review: H5N1 outbreaks in Nepal
Shrestha, D., Bhattachan, B., Parajuli, H., & Shrestha, S. (2021) · Nepal Journal of Biotechnology · doi:10.3126/njb.v9i1.38647 · Cited by 3
Spread of predominant neuraminidase and hemagglutinin co-mutations in the influenza A/H3N2 virus genome
Chong, Y., & Ikematsu, H. (2017) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2017.10.010 · Cited by 3
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v21 · Cited by 3
Characterisation of Vibrio anguillarum for the development of vaccine in cod (Gadus morhua).
Gratacap, R. M. L. (2008) · Stirling Online Research Repository (University of Stirling) · Cited by 3
Testing for genetic mutation of seasonal influenza virus
Liu, V., & Walker, S. G. (2021) · Journal of Applied Statistics · doi:10.1080/02664763.2021.1978955 · Cited by 2
Aspectos básicos, clínicos y epidemiológicos de la Influenza
Orlando Acosta, L., Guerrero, C., & Cortés, J. A. (2009) · Revista de la Facultad de Medicina · Cited by 2
Advancement in Nanomaterials for Rapid Sensing, Diagnosis, and Prevention of COVID-19
Das, D. K., Kumar, A., & Vashistha, V. K. (2021) · Nano LIFE · doi:10.1142/s1793984421300077 · Cited by 4
Mass vaccination in a roaring pandemic
Gaeta, G. (2022) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2021.111786 · Cited by 2
Analyzing Influenza Virus Sequences using Binary Encoding Approach
Lam, H. C., Sreevatsan, S., & Boley, D. L. (2012) · Scientific Programming · doi:10.1155/2012/958482 · Cited by 2
Emergence of mutations and possible antigenic drift in the surface glycoprotein of SARS-CoV-2 (COVID-19)Preprint
Hashimi, S. M. (2020) · doi:10.22541/au.158758096.63683184 · Cited by 2
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in QIV vaccinated micePreprint
Jangra, S., Lamoot, A., Singh, G., Laghlali, G., Chen, Y., Yz, T., García‐Sastre, A., Geest, B. G. D., & Schotsaert, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.14.575599 · Cited by 2
Comparative Analysis of Extracellular Vesicle and Virus Co-Purified Fractions Produced by Contemporary Influenza A and B Viruses in Different Human Cell Lines
Wantchecon, A., Boucher, J., Rabezanahary, H., Gilbert, C., & Baz, M. (2025) · Viruses · doi:10.3390/v17111470 · Cited by 1
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active site
Sornberger, T. A., Wolters, R. M., Gilchuk, I. M., Myers, L., Binshtein, E., Irving, R. P., Chen, E. C., Gilchuk, P., Nargi, R. S., Sutton, R. E., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188887 · Cited by 1
Evaluation of combining the PDX analogue AN-137B with oseltamivir in a mouse model of severe influenza A (H1N1) infection
Abed, Y., Rhéaume, C., Carbonneau, J., Fortin, N., Maltais, R., Marette, A., Poirier, D., & Boivin, G. (2025) · Antiviral Therapy · doi:10.1177/13596535251405300 · Cited by 1
Evolutionary patterns of pH1N1 and H3N2 in relation to vaccine use
Lin, Y.-W., Guo, L.-Z., Tsai, Y.-T., Chu, Y.-C., Lin, Y.-F., Takemura, K., Huang, C.-H., Chang, H.-H., & Lee, C. (2026) · BMC Genomics · doi:10.1186/s12864-026-12608-y · Cited by 1
mRNA vaccines for viral diseases: mechanism, advances, and future perspective
Chakraborty, B., & Singh, T. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11856-1 · Cited by 1
Immunological Responses against Different Lineages of Influenza B Antigen in School Children during Two Consecutive Seasons
Chao, D., Cheng, K.-F., Liao, Y.-H., Liu, M., Hsieh, Y., Li, T., Wu, T., & Chen, C.-Y. (2014) · Health · doi:10.4236/health.2014.621322 · Cited by 1
Differences in the Hemagglutinin Amino Acids of Japanese and US Influenza A/H3N2 Viral Isolates and their Relationship with Vaccine Strain Differences
Chong, Y., & Ikematsu, H. (2017) · Journal of Vaccines & Vaccination · doi:10.4172/2157-7560.1000381
Talking to Patients about the Influenza Vaccine.
Byrd, K. M. (2020) · PubMed · Cited by 1
Single oral immunization of an attenuated Salmonella Gallinarium formulation consisting of equal quantities of strains secreting H9N2 hemagglutinin-HA1, HA2, and M2eCD154 induces significant protection against H9N2 and partial protection against Salmonella Gallinarium challenge in chickens
Senevirathne, A., Hewawaduge, C., Park, S.-W., Jawalagatti, V., Kim, C., Seo, B., Lee, E., & Lee, J. H. (2021) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2021.110318 · Cited by 1
Future Sequon Finder - A novel approach for predicting future N-linked glycosylation sequon locations on viral surface proteins
Bryan, S. P., & Zand, M. S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328174 · Cited by 1
Analyze influenza virus sequences using binary encoding approach
Lam, H. C., & Boley, D. L. (2011) · doi:10.1145/2003351.2003355 · Cited by 1
How Signaling Games Explain Mimicry at Many Levels: From Viral Epidemiology to Human SociologyPreprint
Casey, W., Massey, S. E., & Mishra, B. (2020) · Research Square · doi:10.21203/rs.3.rs-51959/v1 · Cited by 1
Being on the alert for continuously evolving influenza viruses: Early detection and rapid intervention of newly emerging virusesPreprint
Berhanu, M. (2021) · doi:10.31730/osf.io/3kxqc · Cited by 1
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-l393t-v35 · Cited by 1
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v30 · Cited by 1
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v15 · Cited by 1
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-l393t-v33 · Cited by 1
Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicityPreprint
Hodgson, D., Sánchez‐Ovando, S., Carolan, L. A., Liu, Y., Hadiprodjo, A. J., Fox, A., Sullivan, S. G., & Kucharski, A. J. (2024) · medRxiv · doi:10.1101/2024.01.24.24301614 · Cited by 1
The Roles of Cellular Receptor Binding Avidity and Other Viral Phenotypes in the Antigenic Drift of Influenza
Yuan, H. (2013) · DukeSpace (Duke University)
Antigenic variation in Plasmodium falciparum : understanding the RIFIN protein family
Joannin, N. (2010) · Figshare
Predicting protein evolution in vitro by phage escape technology
Rohrbach, A. S., & Dickerson, T. J. (2008) · Molecular BioSystems · doi:10.1039/b814768j
Capture of Influenza Viruses and Prevention of Their Infection by Coral Mineral Powder (Sango Mineral Powder)
TACHIKI, K., Kuramoto, M., Kaneko, M., NAWA, M., NIWA, Y., & Itoh, M. (2012) · Biocontrol Science · doi:10.4265/bio.17.17
Graduate Program in Computational Biology and Bioinformatics
Yuan, H. (2013)
The Efficacy of the Influenza Vaccine and the Implications on Vaccination Policy
DiPietro, A. (2016)
Myxovirus interaction with the human airway epithelium
Scull, M. A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/9k4z-5e11
Complete genome comparison of the recent and historic field strains of African horse sickness virus isolated over four decades
Mokotoane, R. N. (2017) · UpSpace Institutional Repository (University of Pretoria)
Modulation of arbovirus infection by mosquito saliva
Lefteri, D. A., Pondeville, E., Bryden, S. R., Pingen, M., & McKimmie, C. S. (2019) · Access Microbiology · doi:10.1099/acmi.ac2019.po0270
Preparing For the Next Pandemic: Learning Wild Mutational Patterns At Scale For Analyzing Sequence Divergence In Novel PathogensPreprint
Li, J., Li, T., & Chattopadhyay, I. (2020) · medRxiv · doi:10.1101/2020.07.17.20156364
Universal Vaccines against Influenza Viruses: Overview of the Past, Present, and Prospective
Agung, Y., Stacey, H. D., D’Agostino, M. R., & Zhang, A. (2020) · McMaster University Medical Journal · doi:10.15173/mumj.v17i1.2347
Predicting Future Mutations To Inform Vaccine DesignPreprint
Chattopadhyay, I., Li, J., Li, T., & Esser-Kahn, A. P. (2021) · Research Square · doi:10.21203/rs.3.rs-86642/v1
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v32
Aptamers for Detection and Diagnostics (ADD): Can mobile systems linked to biosensors support molecular diagnostics of SARS-CoV-2? Should molecular medicine explore multiple alternatives as adjuvants to or replacement for traditional and non-traditional vaccines?Preprint
Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v35
From transmission to evolution: low pathogenic avian influenza (LPAI) H9N2 evolving under poultry vaccination
Cui, H. (2021) · doi:10.18174/553900
The new Zealand
Jacbs, R. S. W., & BILLING., G. C. (2018)
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v31
Aptamers for Detection and Diagnostics (ADD): Can mobile systems process optical data from aptamer sensors to identify molecules indicating presence of SARS-CoV-2 virus? Should healthcare explore aptamers as drugs for prevention as well as its use as adjuvants with antibodies and vaccines?Preprint
Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v33
Improving year-round protection against influenza infection in the tropics
Young, B. E. (2021) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/155395
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v19
Aptamers for Detection and Diagnostics (ADD): Can mobile systems linked to biosensors support molecular diagnostics of SARS-CoV-2? Should molecular medicine explore multiple alternatives as adjuvants to or replacement for traditional and non-traditional vaccines?Preprint
Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v36
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v20
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v25
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v26
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v28
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v14
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v24
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v18
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v17

Authors: Boni, M. F.
Affiliations: Resources For The Future (US)
Corresponding author: Boni, Maciej F.
ORCID: Boni, Maciej F.
Venue: Vaccine
Publisher: Elsevier BV
Published: 2008-07
Volume: 26
Pages: C8-C14
ISSN: 0264-410X (ISSN-L)
DOI: 10.1016/j.vaccine.2008.04.011
PMC: PMC2603026
OpenAlex: W2023224232
Cited by: 226
References: 48
Citations by year: 2026: 11 · 2025: 13 · 2024: 13 · 2023: 8 · 2022: 14 · 2021: 47 · 2020: 19 · 2019: 9 · 2018: 10 · 2017: 8 · 2016: 9 · 2015: 4 · 2014: 8 · 2013: 10 · 2012: 8
FWCI: 1.18
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Vaccine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Human Genome Research Institute (F32HG000205, HG000205, P01HG000205)
National Institute of General Medical Sciences (GM28016, R01GM028016)
Topics: Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords: influenza vaccination, seasonal influenza, herd immunity, vaccine update, vaccine selection
MeSH terms: Antigenic Variation, Biological Evolution, Humans, Influenza, Human, Influenza Vaccines, Vaccination, Virulence, Genetic Drift, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vaccination and antigenic drift in influenza

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks